HemaSphere - the official open access journal of EHA

HemaSphere is the official open access, peer-reviewed journal of EHA, supporting hematology researchers by offering a fast and constructive review process and low publication fees. The journal publishes results of high-impact basic, translational, and clinical hematology research, as well as insightful review articles with recommendations for future research and clinical applications. To browse HemaSphere, please go to

HemaSphere is the premier hematology information resource, furthering its reach with the journal’s HemaTopics section, which provides insightful discussions on all aspects related to hematology, including reports of new therapies, discussions on European policy, and other related hematology news.

HemaSphere is proud to have a confirmed 2023 impact factor of 12.1.

As well, the journal is fully indexed in PubMed Central (PMC), Scopus (2023 CiteScore of 6.1; May 5, 2024), and in Clarivate Analytics’ Science Citation Index Expanded (SCIE) – Hematology and CC/Clinical Medicine – Hematology sections.

EHA members have the opportunity to publish for a discounted fee in HemaSphere.

We welcome you to access HemaSphere’s exciting content here:

Read the latest articles

Discover our collection of open access articles published in HemaSphere.

Review articles

Explore our collection of Review articles published by HemaSphere.

Submit your paper

EHA members have the opportunity to publish for a discounted fee in HemaSphere.